Effects of Peanuts on Immunity and Cardiometabolic Risk Factors
Status
Conditions
Treatments
Details and patient eligibility
About
The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors.
Full description
The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors . To accomplish this objective, a human dietary intervention trial (RCT) with peanuts is proposed. The proposed study is a 12-week parallel-group, free-living, observer-blind, randomized controlled dietary intervention trial. This study will examine the effects of peanuts on markers of immune function, cardiometabolic markers and risk factors and upper respiratory tract infections, in 80 adult male and female volunteers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- adults between the ages of 18-70 years
Exclusion criteria
- known intolerance or allergy to peanuts
- bad dentures unable to chew peanuts
- regular intake of peanuts and/or other nuts (>3 ounces/week)
- use of immune-boosting supplements
- exposure to antibiotics and corticoids immediately prior to the study
- use of other medications or supplements that can interfere with the immune functions
- Individuals that received any vaccination (i.e flu or Covid 19) 6 months prior to the start of the study
Trial design
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Amandeep Wright, MPH; Joan Sabate, DrPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal